Fulgent Genetics, Inc. (FLGT) Tops Q4 EPS by 2c

Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q4 EPS of $0.06, $0.02 better than the analyst estimate of $0.04. Revenue for the quarter came in at $5.9 million versus the consensus estimate of $6.02 million.

For earnings history and earnings-related data on Fulgent Genetics, Inc. (FLGT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c